PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34440064-8	2021	We found some little difference in the behaviour of the three treatments on some variables: olmesartan was the most effective in reducing fibrinogen, DBP, CRP, and AIx (-13.1%, -19.3%, -21.4%, and -56.8%, respectively).	olmesartan	92-102	C-reactive protein	Homo sapiens	155-158	
34853573-10	2021	Olmesartan significantly decreased ASDAS, BASDAI, BASFI, ESR, CRP, IL-6, TNF-alpha, and SCORE as compared with placebo.	olmesartan	0-10	C-reactive protein	Homo sapiens	62-65	
16939632-6	2006	Angiotensin receptor blockers (ARBs) (valsartan, irbesartan, olmesartan, telmisartan) markedly reduce serum levels of CRP.	olmesartan	61-71	C-reactive protein	Homo sapiens	118-121	
24843534-9	2011	In contrast, the treatment with olmesartan/trichlormethiazide resulted in increased HbA1c, serum uric acid and worsening of estimated glomerular filtration rate, though there were no differences in other metabolic parameters including urine 8-hydroxy-2"-deoxyguanosine, C-reactive protein and adiponectin between the two treatments.	olmesartan	32-42	C-reactive protein	Homo sapiens	270-288